RAMS Systems Policies Forms Events Contact Us

Lines background [View Image]

Office of the Vice President for Research and Innovation

FDA guidance

FDA overview

The FDA provides oversight for clinical trials of investigational drugs, biologic products and medical devices.

Useful links

FDA regulations

Clinical trials involving investigational drugs, biologics and/or devices are governed by specific FDA regulations. Numerous parties involved in the clinical trials process, including study sponsors, principal investigators and institutional review boards, are subject to applicable FDA regulations.

FDA guidance documents and information sheets

The FDA provides guidance documents that describe the FDA's current thinking about issues related to FDA-regulated clinical trials. In addition, the FDA publishes information sheets that provide guidance and recommendations for IRBs, clinical investigators and sponsors to help them fulfill their responsibilities to protect human subjects who participate in FDA-regulated research.

Highlighted guidance

Guidance on FDA form completion

Guidance on clinical trial registration on ClinicalTrials.gov

Device-related guidance

FDA forms/templates

The FDA requires that study sponsors and clinical investigators complete forms specific to the type of study that is being conducted.

Adverse event reporting

FDA compliance findings

The most recent FDA warning letters can be accessed on the FDA website.

Contact us

Lisa Richman Ballance, M.A., CPW, CCP
Executive director for clinical research and compliance
(804) 241-6223
lballanc@vcu.edu 

F. Gerard Moeller, M.D.
Associate vice president for clinical research
(804) 827-1531
fgmoeller@vcu.edu 

Elizabeth B. Collins, M.A., CCRP
VCU FDA regulatory resource program manager and arts in health research liaison
(804) 828-0819
estoddert@vcu.edu 

Emily Komornik
Clinical research communications specialist
(804) 827-2262
komornikea@vcu.edu 

View graphic version